152 related articles for article (PubMed ID: 32274435)
1. Value of
Li X; Tan H
Heliyon; 2020 Apr; 6(4):e03707. PubMed ID: 32274435
[TBL] [Abstract][Full Text] [Related]
2. Multiple values of
Li Y; Zhou Y; Wang Q
Clin Rheumatol; 2017 Oct; 36(10):2297-2305. PubMed ID: 28831580
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary.
Han A; Xue J; Hu M; Zheng J; Wang X
Cancer Epidemiol; 2012 Oct; 36(5):470-5. PubMed ID: 22504050
[TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET/CT versus conventional investigations for cancer screening in autoimmune inflammatory myopathy in the era of novel myopathy classifications.
Maliha PG; Hudson M; Abikhzer G; Singerman J; Probst S
Nucl Med Commun; 2019 Apr; 40(4):377-382. PubMed ID: 30664602
[TBL] [Abstract][Full Text] [Related]
6. Limited screening with versus without (18)F-fluorodeoxyglucose PET/CT for occult malignancy in unprovoked venous thromboembolism: an open-label randomised controlled trial.
Robin P; Le Roux PY; Planquette B; Accassat S; Roy PM; Couturaud F; Ghazzar N; Prevot-Bitot N; Couturier O; Delluc A; Sanchez O; Tardy B; Le Gal G; Salaun PY;
Lancet Oncol; 2016 Feb; 17(2):193-199. PubMed ID: 26672686
[TBL] [Abstract][Full Text] [Related]
7. Value of (18)F-FDG PET/CT in the Detection of Ovarian Malignancy.
Park T; Lee S; Park S; Lee E; Pahk K; Rhee S; Cho J; Kim C; Eo JS; Choe JG; Kim S
Nucl Med Mol Imaging; 2015 Mar; 49(1):42-51. PubMed ID: 25774237
[TBL] [Abstract][Full Text] [Related]
8. Unsuspected Active Ulcerative Colitis in a Patient With Dermatomyositis: A Rare Association Detected on
Rayamajhi SJ; Gorla AKR; Basher RK; Sood A; Mittal BR
Indian J Nucl Med; 2017; 32(2):130-132. PubMed ID: 28533643
[TBL] [Abstract][Full Text] [Related]
9. Clinical value of
Caspersen KB; Giannoutsou N; Gerke O; Alavi A; Høilund-Carlsen PF; Hess S
Ann Nucl Med; 2019 Mar; 33(3):184-192. PubMed ID: 30569441
[TBL] [Abstract][Full Text] [Related]
10. Role of
Dolci C; Ceppi L; Guerra L; Crivellaro C; Lamanna M; Adorni M; Elisei F; Bonazzi CM; Sina F; Fruscio R; Messa C
Int J Gynecol Cancer; 2019 Oct; 29(8):1298-1303. PubMed ID: 31366569
[TBL] [Abstract][Full Text] [Related]
11. Cancer detection with whole-body PET using 2-[18F]fluoro-2-deoxy-D-glucose.
Hoh CK; Hawkins RA; Glaspy JA; Dahlbom M; Tse NY; Hoffman EJ; Schiepers C; Choi Y; Rege S; Nitzsche E
J Comput Assist Tomogr; 1993; 17(4):582-9. PubMed ID: 8331230
[TBL] [Abstract][Full Text] [Related]
12. A pilot study utilizing whole body 18 F-FDG-PET/CT as a comprehensive screening strategy for occult malignancy in patients with unprovoked venous thromboembolism.
Rondina MT; Wanner N; Pendleton RC; Kraiss LW; Vinik R; Zimmerman GA; Heilbrun M; Hoffman JM; Morton KA
Thromb Res; 2012 Jan; 129(1):22-7. PubMed ID: 21802118
[TBL] [Abstract][Full Text] [Related]
13. Whole body 18F-FDG PET/CT imaging in the detection of primary tumours in patients with a metastatic carcinoma of unknown origin.
Kaya AO; Coskun U; Unlu M; Akdemir UO; Ozdemir NY; Zengin N; Benekli M; Yildiz R; Yaman E; Ozturk B; Gumus M; Uner A; Yamac D; Ucgul E; Buyukberber S
Asian Pac J Cancer Prev; 2008; 9(4):683-6. PubMed ID: 19256759
[TBL] [Abstract][Full Text] [Related]
14. Do hyperglycemia and diabetes affect the incidence of false-negative 18F-FDG PET/CT studies in patients evaluated for infection or inflammation and cancer? A Comparative analysis.
Rabkin Z; Israel O; Keidar Z
J Nucl Med; 2010 Jul; 51(7):1015-20. PubMed ID: 20554733
[TBL] [Abstract][Full Text] [Related]
15. The clinical significance of 18F-FDG-PET/CT in early detection of second primary malignancy in cancer patients.
Xu H; Zhang M; Zhai G; Li B
J Cancer Res Clin Oncol; 2010 Aug; 136(8):1125-34. PubMed ID: 20091320
[TBL] [Abstract][Full Text] [Related]
16. Benefits and harms of implementing [
Vogsen M; Jensen JD; Gerke O; Jylling AMB; Asmussen JT; Christensen IY; Braad PE; Thye-Rønn P; Søe KL; Ewertz M; Hildebrandt MG
EJNMMI Res; 2021 Sep; 11(1):93. PubMed ID: 34553294
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Value of
Georga S; Exadaktylou P; Petrou I; Katsampoukas D; Mpalaris V; Moralidis EI; Arvaniti K; Papastergiou C; Arsos G
J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32635566
[TBL] [Abstract][Full Text] [Related]
18. Role of
Budak E; Yanarateş A
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(1):14-19. PubMed ID: 31744788
[TBL] [Abstract][Full Text] [Related]
19. 18F-FDG PET detection of unknown primary malignancy in dermatomyositis.
Mahmood S; Rodríguez Martínez de Llano S
Clin Nucl Med; 2012 Aug; 37(8):e204-5. PubMed ID: 22785528
[TBL] [Abstract][Full Text] [Related]
20. Abass Alavi: A giant in Nuclear Medicine turns 80 and is still going strong!
Høilund-Carlsen PF
Hell J Nucl Med; 2018; 21(1):85-87. PubMed ID: 29550853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
